Strong Medicine? After Decades of Diluted Enforcement, FDA Issues Draft Guidance Announcing New Enforcement Policy for Homeopathic Drugs That Takes a Risk-Based Approach
On December 18, 2017, the U.S. Food and Drug Administration (FDA) issued its long-awaited Draft Guidance for Industry: Drug Products Labeled as … more